Zobrazeno 1 - 10
of 1 376
pro vyhledávání: '"Whynes, D"'
Autor:
Whynes, D. K.
Publikováno v:
Quality of Life Research, 1997 Jan 01. 6(1), 61-66.
Externí odkaz:
https://www.jstor.org/stable/4035286
Publikováno v:
The Journal of the Operational Research Society, 1996 Dec 01. 47(12), 1443-1451.
Externí odkaz:
https://www.jstor.org/stable/3010602
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Laryngology & Otology; May2023, Vol. 137 Issue 5, p541-545, 5p
Autor:
Goyal, A., Mann, G.B., Fallowfield, L., Duley, L., Reed, M., Dodwell, D., Coleman, R.E., Fakis, A., Newcombe, R., Jenkins, V., Whitham, D., Childs, M., Whynes, D., Keeley, V., Ellis, I., Fairbrother, P., Sadiq, S., Monson, K., Montgomery, A., Tan, W., Vale, L., Homer, T., Badger, H., Haines, R.H., Lewis, M., Megias, D., Nabi, Z., Singh, P., Caraman, A., Miles, E., POSNOC Trialists, (on behalf of)
Publikováno v:
BMJ Open
Introduction: ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in women with ≤2 positive nodes undergoing breast conserving surgery (BCS) and whole breast radiotherapy (RT). A confirmatory study is needed to clarify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::af18dfda1765b0211291dea334392cf3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Whynes, D. K.
Publikováno v:
Quality of Life Research, 1994 Jun 01. 3(3), 191-198.
Externí odkaz:
https://www.jstor.org/stable/4035094
Autor:
Janet George
Publikováno v:
International Social Work. 31:55-56
Autor:
Bös, Dieter1,2
Publikováno v:
Economica. Aug82, Vol. 49 Issue 195, p367-368. 2p.
Autor:
Goyal A; Department of Surgery, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK amit.goyal@nhs.net., Mann GB; Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.; Breast Cancer Trials, Newcastle, New South Wales, Australia., Fallowfield L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK., Duley L; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Reed M; Brighton and Sussex Medical School, Brighton, UK., Dodwell D; Nuffield Department of Population Health, Oxford University, Oxford, UK., Coleman RE; Department of Oncology and Metabolism, Weston Park Hospital, Sheffield, UK., Fakis A; Research and Development, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK., Newcombe R; Department of Primary Care and Public Health, Cardiff University, Cardiff, UK., Jenkins V; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK., Whitham D; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Childs M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Whynes D; School of Economics, University of Nottingham, Nottingham, UK., Keeley V; Lymphoedema Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK., Ellis I; School of Medicine, University of Nottingham, Nottingham, UK., Fairbrother P; Patient Advocate, Independent Cancer Patients' Voice, London, UK., Sadiq S; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Monson K; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK., Montgomery A; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Tan W; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Vale L; Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Homer T; Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Badger H; Breast Cancer Trials, Newcastle, New South Wales, Australia., Haines RH; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Lewis M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Megias D; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK., Nabi Z; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK., Singh P; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK., Caraman A; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK., Miles E; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Dec 02; Vol. 11 (12), pp. e054365. Date of Electronic Publication: 2021 Dec 02.